Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
70.79
-0.20 (-0.28%)
At close: Mar 23, 2026, 4:00 PM EDT
70.70
-0.09 (-0.13%)
Pre-market: Mar 24, 2026, 8:31 AM EDT
Ionis Pharmaceuticals Analyst Ratings
Total Analysts
22
Consensus Rating
Strong Buy
Price Target
$85.91
Upside
+21.36%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $102 → $104 | Buy | Maintains | $102 → $104 | +46.91% | Mar 3, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $87 → $100 | Buy | Maintains | $87 → $100 | +41.26% | Feb 27, 2026 |
| Stifel | Stifel | Hold Maintains $73 → $77 | Hold | Maintains | $73 → $77 | +8.77% | Feb 26, 2026 |
| Needham | Needham | Strong Buy Maintains $90 → $103 | Strong Buy | Maintains | $90 → $103 | +45.50% | Feb 26, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $77 → $87 | Buy | Maintains | $77 → $87 | +22.90% | Feb 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $82 → $100 | Buy | Maintains | $82 → $100 | +41.26% | Jan 5, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $82 → $95 | Buy | Maintains | $82 → $95 | +34.20% | Dec 17, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $85 → $100 | Buy | Maintains | $85 → $100 | +41.26% | Dec 15, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $86 → $97 | Strong Buy | Maintains | $86 → $97 | +37.03% | Dec 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +55.39% | Nov 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $70 → $77 | Buy | Maintains | $70 → $77 | +8.77% | Nov 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $59 → $99 | Strong Buy | Maintains | $59 → $99 | +39.85% | Oct 30, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $90 → $94 | Buy | Maintains | $90 → $94 | +32.79% | Oct 30, 2025 |
| Barclays | Barclays | Buy Maintains $80 → $95 | Buy | Maintains | $80 → $95 | +34.20% | Oct 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $95 → $100 | Strong Buy | Maintains | $95 → $100 | +41.26% | Oct 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $80 → $82 | Buy | Maintains | $80 → $82 | +15.84% | Oct 30, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.